C12N 2795/10352
Relating to complementing cells and packaging systems for producing virus or viral
Official title: relating to complementing cells and packaging systems for producing virus or viral particles
C12N2795/10352 (Relating to complementing cells and packaging systems for producing virus or viral) appears on 18 US grants and 24 published applications in this corpus.
Search patents in C12N- Granted patents
- 18
- Published applications
- 24
- Assignees
- 4
- Inventors
- 26
- Latest grant
- 4 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2013 | 0 | 1 |
| 2014 | 0 | 1 |
| 2015 | 0 | 1 |
| 2016 | 1 | 2 |
| 2017 | 2 | 2 |
| 2018 | 1 | 0 |
| 2019 | 2 | 1 |
| 2020 | 0 | 1 |
| 2021 | 1 | 0 |
| 2022 | 1 | 4 |
| 2023 | 5 | 3 |
| 2024 | 3 | 6 |
| 2025 | 2 | 0 |
| 2026 | 0 | 2 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Phage-derived particles for in situ delivery of DNA payload into C. acnes population4 Nov 2025US 12,460,216 B2Eligo Bioscience
- Cutibacterium acnes recombinant phages encoding a human protein28 Oct 2025US 12,454,696 B2Eligo Bioscience
- Phage-derived particles for in situ delivery of DNA payload into C. acnes population30 Apr 2024US 11,970,701 B2Eligo Bioscience
- Production of lytic phages9 Apr 2024US 11,952,595 B2Eligo Bioscience
- Production bacterial cells and use thereof in production methods26 Mar 2024US 11,939,598 B2Eligo Bioscience
- Cutibacterium acnes recombinant phages, method of production and uses thereof6 Aug 2026US 2026/0226484 A1Eligo Bioscience
- Phage-derived particles for in situ delivery of dna payload into c. acnes population23 Apr 2026US 2026/0109991 A1Eligo Bioscience
- Phage-derived particles for in situ delivery of dna payload into c. acnes population1 Aug 2024US 2024/0254496 A1Eligo Bioscience
- Production of lytic phages25 Jul 2024US 2024/0247238 A1Eligo Bioscience
- Production bacterial cells and use thereof in production methods6 Jun 2024US 2024/0182870 A1Eligo Bioscience
Most cited
By later US patents
- Non-replicative transduction particles and transduction particle-based reporter systems11US 9,388,453 B2GeneWeave Biosciences, Inc. · 2016
- Non-replicative transduction particles and transduction particle-based reporter systems4US 9,771,622 B2GeneWeave Biosciences, Inc. · 2017
- Cutibacterium acnes recombinant phages, method of production and uses thereof1US 11,473,093 B2Eligo Bioscience · 2022
- Production of lytic phages1US 11,739,304 B2Eligo Bioscience · 2023
- Non-replicative transduction particles and transduction particle-based reporter systems1US 9,752,200 B2GeneWeave Biosciences, Inc. · 2017